Related Experiment Video
Updated: Aug 29, 2026

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
Published on: August 2, 2021
Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in down-regulated Th1
Nicolle H R Litjens1, Mirjam Rademaker, Bep Ravensbergen
1Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Abstract:
Psoriasis vulgaris, a type-1 cytokine-mediated chronic skin disease, can be treated successfully with fumaric acid esters (FAE). Beneficial effects of this medication coincided with decreased production of IFN-gamma. Since dendritic cells (DC) regulate the differentiation of T helper (Th) cells, this study focussed on effects of monomethylfumarate (MMF, bioactive metabolite of FAE) on polarization of monocyte-derived DC. MMF-incubated, lipo-polysaccharide-stimulated DC (MMF-DC) produced dramatically (p<0.05) reduced levels of IL-12p70 and IL-10 (8+/-4% and 20+/-4%, respectively) compared to control DC. MMF-DC were mature. MMF affected polarization of DC irrespective of polarization factor(s) and ligands for the various Toll-like receptors used. Coculture of MMF-DC with naive and primed allogenous Th cells resulted in lymphocytes producing less IFN-gamma, i.e. 59% and 54% of that by the respective Th cells cocultured with control DC. IL-4 production by primed, but not naive Th cells cocultured with MMF-DC was decreased as compared to cocultures with control DC. IL-10 production by naive and primed Th cells cocultured with MMF-DC and control DC did not differ. In addition, MMF inhibited LPS-induced NF-kappaB activation in DC. Together, beneficial effects of FAE in psoriasis involve modulation of DC polarization by MMF such that these cells down-regulate IFN-gamma production by Th cells.
Insights
Monomethylfumarate (MMF), a fumaric acid ester metabolite, reduces key inflammatory cytokines from dendritic cells (DC). This modulation of DC polarization by MMF helps decrease T helper cell-driven IFN-gamma production, offering benefits for psoriasis treatment.
Area of Science:
- Immunology
- Dermatology
- Pharmacology
Background:
- Psoriasis vulgaris is a chronic skin disease driven by type-1 cytokines.
- Fumaric acid esters (FAE) are effective treatments for psoriasis, associated with reduced IFN-gamma.
- Dendritic cells (DC) are crucial in regulating T helper (Th) cell differentiation.
Purpose of the Study:
- To investigate the effects of monomethylfumarate (MMF), the active metabolite of FAE, on the polarization of monocyte-derived DC.
- To understand how MMF influences DC cytokine production and their subsequent impact on Th cell responses.
Main Methods:
- Monocyte-derived DC were stimulated with lipopolysaccharide (LPS) and treated with MMF.
- Cytokine production (IL-12p70, IL-10, IFN-gamma, IL-4) was measured from DC and co-cultured Th cells.
- NF-kappaB activation in DC was assessed following LPS stimulation with or without MMF.
Main Results:
- MMF-treated DC (MMF-DC) showed significantly reduced production of IL-12p70 and IL-10 compared to control DC.
- Co-culture with MMF-DC led to decreased IFN-gamma production by both naive and primed Th cells.
- MMF inhibited LPS-induced NF-kappaB activation in DC, indicating an effect on inflammatory signaling pathways.
Conclusions:
- MMF modulates DC polarization, leading to down-regulation of IFN-gamma production by Th cells.
- These findings suggest that MMF's beneficial effects in psoriasis treatment involve the modulation of DC function.
- FAE treatment efficacy in psoriasis may be linked to MMF's ability to alter DC-Th cell interactions and reduce pro-inflammatory cytokine output.
More Related Videos
10:43Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection
Published on: September 18, 2020
11:34A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025